SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (10)6/12/1997 5:09:00 PM
From: biowa   of 3044
 
Pseudo Biologist,

No disappointment in our discussions. As to the the pre-clinical progress of any MLNM-based products, the best source is a chart in the May 1996 prospectus (p. 33) that shows the progress of the six major diesease research programs. It shows several genes in obesity, atherosclerosis, inflam. resp. disease and oncology in the target validation stage (essentially biological study of the gene function), and none in product development. As far as I'm aware this is still an accurate portrayal, though I'm sure several more have entered target validation.

What other threads might hold interested lurkers (Sequana, Myriad, HGSI...)? Perhaps between this, the INCY and VD threads we can get some good two-sided debates going on genomics?

biowa
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext